Gland Pharma Stock Forecast

Sell candidate since Nov 04, 2025 Loss -6.44%

The Gland Pharma Limited stock price fell by -1.38% on the last day (Tuesday, 18th Nov 2025) from ₹1,814.60 to ₹1,789.55. During the last trading day the stock fluctuated 1.96% from a day low at ₹1,787.00 to a day high of ₹1,822.05. The price has fallen in 8 of the last 10 days and is down by -9.26% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -1 thousand shares and in total, 3 thousand shares were bought and sold for approximately ₹4.57 million.

The stock has broken the falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point (₹1,804.24) are considered to be a "second chance" to get out. According to the fan-theory ₹1,631.72 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

GLAND.BO Signals & Forecast

There are few to no technical positive signals at the moment. The Gland Pharma Limited stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at ₹1,832.39 and ₹1,915.51. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, November 03, 2025, and so far it has fallen -9.26%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Gland Pharma Limited stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved ₹35.05 (1.96%) between high and low. For the last week, the stock has had daily average volatility of 2.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (GLAND.BO) For The Upcoming Trading Day Of Wednesday 19th

For the upcoming trading day on Wednesday, 19th we expect Gland Pharma Limited to open at ₹1,799.53, and during the day (based on 14 day Average True Range), to move between ₹1,765.19 and ₹1,813.91, which gives a possible trading interval of +/-₹48.72 (+/-2.76%) up or down from last closing price. If Gland Pharma Limited takes out the full calculated possible swing range there will be an estimated 2.76% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ ₹1,912.75, some ₹123.20 (6.88%) from the current price of ₹1,789.55, our system finds the risk reward not very attractive.

Is Gland Pharma Limited stock A Buy?

Gland Pharma Limited holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -2.469 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 19, 2025 - ₹1,799.53 ( 0.558%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk